A summary of current health news including Cigna's profit decline, Robert F. Kennedy Jr.'s Senate hearings, an Ebola outbreak ...

Co., Inc. (NYSE:MRK), a global healthcare leader, faces a complex landscape of opportunities and challenges as it navigates the competitive biopharmaceutical industry. This comprehensive analysis ...

We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this article, we are going to take a ...

Forward-Looking Statement of Merck & Co., Inc., Rahway ... health care legislation in the United States and internationally; global trends toward health care cost containment; technological ...

A global pharmaceutical company partnered with DelveInsight to create a robust and simplified solution enabling its top ...

Herrmann will continue in her role as chief of staff to EVP and chief communications and public affairs officer Cristal Downing.

Merck has high hopes for Winrevair to be among the portfolio of assets that will blossom as the company loses patent protection for cancer superstar Keytruda later this decade. Merck gained ...

We recently published a list of 12 Best Dow Stocks to Buy Right Now. In this article, we are going to take a look at where ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... According to S&P Global, from the past 30 years up until June 2021, the market returned 10.6%, while the index ...

The latest health news includes Robert F. Kennedy Jr.'s nomination, Abbott's strategy amid global challenges, and Purdue Pharma's opioid settlement. It highlights company strategies, profits, and ...

Today's Research Daily features a real-time update on the Q4 earnings season and fresh Chevron (CVX), Merck (MRK), QUALCOMM ...

Discover why Merck presents a compelling long-term investment opportunity with its discounted valuation, robust pipeline, and strong financial performance.